These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28323056)

  • 1. FTY720 promotes pulmonary fibrosis when administered during the remodelling phase following a bleomycin-induced lung injury.
    Gendron DR; Lemay AM; Lecours PB; Perreault-Vallières V; Huppé CA; Bossé Y; Blanchet MR; Dion G; Marsolais D
    Pulm Pharmacol Ther; 2017 Jun; 44():50-56. PubMed ID: 28323056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
    Wang L; Sammani S; Moreno-Vinasco L; Letsiou E; Wang T; Camp SM; Bittman R; Garcia JG; Dudek SM
    Crit Care Med; 2014 Mar; 42(3):e189-99. PubMed ID: 24335440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
    He F; Zhou A; Feng S
    PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice.
    Conte E; Iemmolo M; Fagone E; Gili E; Fruciano M; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
    Immunobiology; 2014 Jun; 219(6):425-31. PubMed ID: 24613476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
    Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
    Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model.
    Shieh JM; Tseng HY; Jung F; Yang SH; Lin JC
    Mediators Inflamm; 2019; 2019():7947596. PubMed ID: 31049028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mizoribine protects against bleomycin-induced lung injury.
    Matsui K; Ueda H; Terada M; Azuma N; Okamura H; Sano H
    Mod Rheumatol; 2010 Oct; 20(5):471-7. PubMed ID: 20490597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function.
    Murphy S; Lim R; Dickinson H; Acharya R; Rosli S; Jenkin G; Wallace E
    Cell Transplant; 2011; 20(6):909-23. PubMed ID: 21092408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
    Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
    Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS5 Determines Neutrophil Migration in the Acute Inflammatory Phase of Bleomycin-Induced Lung Injury.
    Sharma N; Nagaraj C; Nagy BM; Marsh LM; Bordag N; Zabini D; Wygrecka M; Klepetko W; Gschwandtner E; Genové G; Heinemann A; Weir EK; Kwapiszewska G; Olschewski H; Olschewski A
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition.
    Ryu J; Jhun J; Park MJ; Baek JA; Kim SY; Cho KH; Choi JW; Park SH; Choi JY; Cho ML
    J Transl Med; 2020 Jun; 18(1):225. PubMed ID: 32505218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 attenuates paraquat-induced lung injury in mice.
    Qian J; Ye Y; Lv L; Zhu C; Ye S
    Int Immunopharmacol; 2014 Aug; 21(2):426-31. PubMed ID: 24893116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
    Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
    Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models.
    Huang Z; Liu H; Zhang X; Wen G; Zhu C; Zhao Y; Niu W; Qin Y; Chen H; Bai C; Liu G
    Int Immunopharmacol; 2018 Oct; 63():26-34. PubMed ID: 30064040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice.
    Liu HZ; Yang HZ; Mi S; Cui B; Hua F; Hu ZW
    Yao Xue Xue Bao; 2010 Aug; 45(8):976-86. PubMed ID: 21348427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise attenuates pulmonary injury in mice with bleomycin-induced pulmonary fibrosis.
    Prata LO; Oliveira FM; Ribeiro TM; Almeida PW; Cardoso JA; Rodrigues-Machado Mda G; Caliari MV
    Exp Biol Med (Maywood); 2012 Aug; 237(8):873-83. PubMed ID: 22903133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosis.
    Derseh HB; Goodger JQD; Scheerlinck JY; Samuel CS; Woodrow IE; Palombo EA; Cumming A; Snibson K
    PLoS One; 2021; 16(12):e0260719. PubMed ID: 34855848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
    Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
    Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.